Status:
RECRUITING
Characterization of Placental Diffusion
Lead Sponsor:
Hillel Yaffe Medical Center
Conditions:
Pregnancy in Diabetic
Placenta Diseases
Eligibility:
FEMALE
18-50 years
Phase:
NA
Brief Summary
DW-MRI Allows a quantitative comparison of diffusion as an expression of tissue hypoxia. The investigators aim is to compare changes in placental diffusion in pregnant women with uncontrolled diabetes...
Detailed Description
In highly uncontrolled diabetes there is an increased risk of intrauterine fetal death. The mechanism of fetal death is unknown and unpredictable. One of the theories points to hypoxia as a precursor ...
Eligibility Criteria
Inclusion
- Women with PGAM (Pre-gestational diabetes) diagnosed before 20 weeks of pregnancy
- Women with GDMA (Gestational diabetes) diagnosed by OGTT after 20 weeks of pregnancy
Exclusion
- pregnant women with placental hypoxia disease related in the past
- pregnant women with placental hypoxia disease related in the present
- non-singleton pregnancy
- women in active labor or rupture of membrane
- smoking women
- suspicion of placenta accreta
Key Trial Info
Start Date :
July 6 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2027
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06992245
Start Date
July 6 2023
End Date
December 1 2027
Last Update
December 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hille Yaffe Medical Center
Hadera, Israel, 38100